within Pharmacolibrary.Drugs.ATC.A;

model A10AC02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 1.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0002666666666666667,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Insulin (beef) is a naturally derived hormone replacement used for the treatment of diabetes mellitus. It was extracted from bovine pancreas and historically used for glycemic control in both type 1 and type 2 diabetes before widespread adoption of recombinant human insulin. It is rarely used today due to immunogenicity and availability of human and analog insulins.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for subcutaneous administration in adult type 1 diabetes patients, based on data available for exogenous insulin products from historical clinical experience. No direct PK study for bovine insulin in literature.</p><h4>References</h4><ol><li><p>Larkins, RG (1983). Human insulin. <i>Australian and New Zealand journal of medicine</i> 13(6) 647–651. DOI:<a href=&quot;https://doi.org/10.1111/j.1445-5994.1983.tb02628.x&quot;>10.1111/j.1445-5994.1983.tb02628.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6372774/&quot;>https://pubmed.ncbi.nlm.nih.gov/6372774</a></p></li><li><p>Hildebrandt, P, et al., &amp; Kühl, C (1985). The subcutaneous absorption of human and bovine ultralente insulin formulations. <i>Diabetic medicine : a journal of the British Diabetic Association</i> 2(5) 355–359. DOI:<a href=&quot;https://doi.org/10.1111/j.1464-5491.1985.tb00650.x&quot;>10.1111/j.1464-5491.1985.tb00650.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2951089/&quot;>https://pubmed.ncbi.nlm.nih.gov/2951089</a></p></li><li><p>Brogard, JM, et al., &amp; Paris-Bockel, D (1985). Genetically engineered insulin: five years of experience. <i>Drugs under experimental and clinical research</i> 11(6) 397–406. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3915289/&quot;>https://pubmed.ncbi.nlm.nih.gov/3915289</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A10AC02;
